双级靶向纳米载体在脑肿瘤诊断和治疗方面的应用

高洪元; 吴建勇; 倪曙民

doi:10.3969/j.issn.1006-0111.2015.01.003

双级靶向纳米载体在脑肿瘤诊断和治疗方面的应用

doi: 10.3969/j.issn.1006-0111.2015.01.003

1.
复旦大学附属华山医院静安分院肿瘤科, 上海 200040
2.
复旦大学附属华山医院静安分院临床药理科, 上海 200040
3.
宁波大学附属医院肿瘤科, 浙江宁波 315020

Application of dual-targeting nano-carriers in diagnosis and therapy of brain tumors

1.
Huashan Hospital Affiliated to Fudan University Jing'an Branch, Department of Oncology, Shanghai 200041, China
2.
Huashan Hospital Affiliated to Fudan University Jing'an Branch, Department of Clinical Pharmacology, Shanghai 200041, China
3.
Department of Oncology, Affiliated Hospital of Ningbo University, Ningbo 315020, China

摘要: 血脑屏障的存在严重阻碍了脑肿瘤化疗药物向脑内递送。纳米粒、脂质体、胶束等纳米载体可显著增加药物的穿过血脑屏障转运的能力,采用单一或双功能基制备的双级靶向纳米载体还可进一步增加药物的脑内递送及在脑肿瘤病变部位的浓集,从而显著提高脑肿瘤的诊断和治疗效果。笔者主要介绍双级靶向纳米载体的设计思路、靶向功能基的最新研究进展,为相关研究提供参考。
- 双级靶向 /
- 纳米载体 /
- 脑肿瘤 /
- 诊断 /
- 治疗
Abstract: The delivery of therapeutical agents for brain tumors' treatment is enormously prevented by the presence of blood-brain barrier.Nano-carriers such as nano-particles,liposomes and micelles can significantly increase the transport of drugs across the blood-brain barrier.The dual-targeting nano-carriers modified by one or two functional groups can further increase the brain delivery of drugs as well as their accumulation in brain tumors,resulting in significant improvement in the diagnosis and therapy of brain tumors.This article mainly focused on the recent development of strategies and functional groups of dual-targeting nano-carriers,providing a reference for relevant investigations.
- dual-targeting /
- nano-carrier /
- brain tumor /
- diagnosis /
- therapy

[1]	Pardridge WM.BBB-Genomics:creating new openings for brain-drug targeting[J].Drug Discov Today,2001,6(8):381-383.
[2]	van Rooy I,Mastrobattista E,Storm G,et al.Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain[J].J Control Release,2011,150(1):30-36.
[3]	Chen H,Qin Y,Zhang Q,et al.Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas[J]. Eur J Pharm Sci,2011,44(1-2):164-173.
[4]	Demeule M,Currie JC,Bertrand Y,et al.Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2[J].J Neurochem,2008,106(4):1534-1544.
[5]	Xin H,Jiang X,Gu J,et al.Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma[J].Biomaterials,2011,32(18):4293-4305.
[6]	Xin H,Sha X,Jiang X,et al.Anti-glioblastoma efficacy and safety of paclitaxel-loading angiopep-conjugated dual targeting PEG-PCL nanoparticles[J].Biomaterials,2012,33(32):8167-8176.
[7]	Xin H,Sha X,Jiang X,et al.The brain targeting mechanism of angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles[J].Biomaterials,2012,33(5):1673-1681.
[8]	Huang S,Li J,Han L,et al.Dual targeting effect of angiopep-2-modified,DNA-loaded nanoparticles for glioma[J].Biomaterials,2011,32(28):6832-6838.
[9]	Ren J,Shen S,Wang D,et al.The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2[J].Biomaterials,2012,33(11):3324-3333.
[10]	Li J,Zhou L,Ye D,et al.Choline-derivate-modified nanoparticles for brain-targeting gene delivery[J].Adv Mater,2011,23(39):4516-4520.
[11]	Machová E,O'Regan S,Newcombe J,et al.Detection of choline transporter-like 1 protein CTL1 in neuroblastoma x glioma cells and in the CNS,and its role in choline uptake[J].J Neurochem,2009,110(4):1297-1309.
[12]	Li J,Guo Y,Kuang Y,et al.Choline transporter-targeting and co-delivery system for glioma therapy[J].Biomaterials,2013,34(36):9142-9148.
[13]	Li J,Huang S,Shao K,et al.A choline derivate-modified nanoprobe for glioma diagnosis using MRI[J].Sci Rep,2013,3:1623.
[14]	Malcor JD,Payrot N,David M,et al.Chemical optimization of new ligands of the low-density lipoprotein receptor as potential vectors for central nervous system targeting[J].J Med Chem,2012,55(5):2227-2241.
[15]	Zhang B,Sun X,Mei H,et al.LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma[J].Biomaterials,2013,34(36):9171-9182.
[16]	Zhu L,Wang H,Wang L,et al.High-affinity peptide against MT1-MMP for in vivo tumor imaging[J].J Control Release,2011, 150(3):248-255.
[17]	Gu G,Gao X,Hu Q,et al.The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells[J].Biomaterials,2013,34(21):5138-5148.
[18]	Li J,Feng L,Fan L,et al.Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides[J].Biomaterials,2011,32(21):4943-4950.
[19]	Guo J,Gao X,Su L,et al.Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery[J].Biomaterials,2011,32(31):8010-8020.
[20]	Gao H,Qian J,Cao S,et al.Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles[J].Biomaterials,2012,33(20):5115-5123.
[21]	Gao JQ,Lv Q,Li LM,et al.Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes[J].Biomaterials,2013,34(22):5628-5639.
[22]	Paleĉek J,Dräger G,Kirschning A.A practical large-scale synthesis of cyclic RGD pentapeptides suitable for further functionalization through‘click’chemistry[J].Synthesis,2011,(4):653-661.
[23]	Zhang P,Hu L,Yin Q,et al.Transferrin-modified c[RGDfK]-paclitaxel loaded hybrid micelle for sequential blood-brain barrier penetration and glioma targeting therapy[J].Mol Pharm,2012,9(6):1590-1598.
[24]	Sugimoto Y,Tsukahara S,Imai Y,et al.Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists[J].Mol Cancer Ther,2003,2(1):105-112.
[25]	Tian W,Ying X,Du J,et al.Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing rats[J].Eur J Pharm Sci,2010,41(2):232-243.
[26]	He H,Li Y,Jia XR,et al.PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors[J].Biomaterials,2011,32(2):478-487.
[27]	Du J,Lu WL,Ying X,et al.Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals[J].Mol Pharm,2009,6(3):905-917.

[1]	毛智毅, 王筱燕, 陈晓颖, 汤逸斐. 度拉糖肽联合二甲双胍对肥胖型2型糖尿病患者机体代谢、体脂成分及血清脂肪因子的影响 . 药学实践与服务, 2024, 42(7): 305-309. doi: 10.12206/j.issn.2097-2024.202305032
[2]	陈静, 何瑞华, 翁月, 徐熠, 刘静, 黄瑾. 基于网络药理学和分子对接技术探究定清片活性成分治疗白血病的作用机制 . 药学实践与服务, 2024, 42(11): 1-8. doi: 10.12206/j.issn.2097-2024.202401073
[3]	刘丽艳, 余小翠, 孙传铎. 纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(10): 451-456. doi: 10.12206/j.issn.2097-2024.202310044
[4]	迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛. 负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架用于创伤性脑损伤治疗 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202406034
[5]	宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅. 帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
[6]	丁华敏, 郭羽晨, 秦春霞, 宋志兵, 孙莉莉. 消风止痒颗粒通过降低白三烯水平对小鼠特应性皮炎急性瘙痒的治疗作用研究 . 药学实践与服务, 2024, 42(5): 211-216. doi: 10.12206/j.issn.2097-2024.202306031
[7]	戴菲菲, 傅翔, 陈琼年, 俞苏纯. 上海某二级医院革兰阴性菌流行特征的回顾性分析 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202305005
[8]	陈春娟, 郑志新, 李骊. 平喘方联合孟鲁司特钠治疗儿童支气管哮喘患者的临床疗效观察 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202405035
[9]	唐淑慧, 凤美娟, 薛智霞, 鲁桂华. 帕博利珠单抗治疗所致免疫相关不良反应与中医体质的相关性研究 . 药学实践与服务, 2024, 42(5): 217-222. doi: 10.12206/j.issn.2097-2024.202311029
[10]	景凯, 杨慈荣, 张圳, 臧艺蓓, 刘霞. 黄芪甲苷衍生物治疗慢性心力衰竭小鼠的药效评价及作用机制研究 . 药学实践与服务, 2024, 42(5): 190-197. doi: 10.12206/j.issn.2097-2024.202310004
[11]	练鲁英, 刘盈, 殷佳, 诸国樑, 徐飞. 上海某三级公立医院药品管理内部控制评价实践研究 . 药学实践与服务, 2024, 42(): 1-7. doi: 10.12206/j.issn.2097-2024.202402003
[12]	张晶晶, 索丽娜, 郑兆红. 89例细菌性肝脓肿的临床特征及抗感染治疗分析 . 药学实践与服务, 2024, 42(6): 267-272. doi: 10.12206/j.issn.2097-2024.202302039
[13]	郭灵怡, 刘艳超, 高路, 刘瑞瑶, 吕权真, 俞媛. 醋酸卡泊芬净单硬脂酸甘油酯纳米粒抗白色念珠菌感染的增效作用研究 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202310043
[14]	舒飞, 孙蕊, 宋凯, 张元林, 闫家铭, 舒丽芯. 粉-液双室袋产品综合评估 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202312009
[15]	陈莹, 许子华, 胡北, 崔亚玲, 高欢, 吴琼. 通便灵胶囊治疗便秘的药效与机制研究 . 药学实践与服务, 2024, 42(): 1-7. doi: 10.12206/j.issn.2097-2024.202404008
[16]	邹思, 吴岩斌, 吴锦忠, 吴建国, 黄家兴. 虎奶菇菌核多糖功能化纳米硒抗疲劳功效研究 . 药学实践与服务, 2024, 42(10): 426-432. doi: 10.12206/j.issn.2097-2024.202206072
[17]	宋泽成, 陈林林, 鲁仁义, 刘梦肖, 王彦. 脓毒症治疗的研究进展 . 药学实践与服务, 2024, 42(11): 1-5. doi: 10.12206/j.issn.2097-2024.202405059
[18]	马兹芬, 许维恒, 金煜翔, 薛磊. 食管癌的靶向治疗与免疫治疗研究进展 . 药学实践与服务, 2024, 42(6): 231-237. doi: 10.12206/j.issn.2097-2024.202306008
[19]	孙丹倪, 黄勇, 张嘉宝, 王培. 代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049

点击查看大图

计量

文章访问数: 3033
HTML全文浏览量: 288
PDF下载量: 86
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

双级靶向纳米载体在脑肿瘤诊断和治疗方面的应用

doi: 10.3969/j.issn.1006-0111.2015.01.003

Application of dual-targeting nano-carriers in diagnosis and therapy of brain tumors

计量

双级靶向纳米载体在脑肿瘤诊断和治疗方面的应用

doi: 10.3969/j.issn.1006-0111.2015.01.003

1. 复旦大学附属华山医院静安分院肿瘤科, 上海 200040

2. 复旦大学附属华山医院静安分院临床药理科, 上海 200040

3. 宁波大学附属医院肿瘤科, 浙江宁波 315020

English Abstract

Application of dual-targeting nano-carriers in diagnosis and therapy of brain tumors

全文HTML

目录

留言板

双级靶向纳米载体在脑肿瘤诊断和治疗方面的应用

doi: 10.3969/j.issn.1006-0111.2015.01.003

Application of dual-targeting nano-carriers in diagnosis and therapy of brain tumors

计量

出版历程

双级靶向纳米载体在脑肿瘤诊断和治疗方面的应用

doi: 10.3969/j.issn.1006-0111.2015.01.003

1. 复旦大学附属华山医院静安分院 肿瘤科, 上海 200040 2. 复旦大学附属华山医院静安分院 临床药理科, 上海 200040 3. 宁波大学附属医院肿瘤科, 浙江 宁波 315020

English Abstract

Application of dual-targeting nano-carriers in diagnosis and therapy of brain tumors

全文HTML

目录

1. 复旦大学附属华山医院静安分院肿瘤科, 上海 200040

2. 复旦大学附属华山医院静安分院临床药理科, 上海 200040

3. 宁波大学附属医院肿瘤科, 浙江宁波 315020